semaglutide and bipolar Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in disorder: a narrative review of preclinical clinical evidence Glucagon-like peptide-1 medicines in neurological

doi: 10.1046/j.1365-2826.1998.00182.x 148 PavlatouMGMastorakosGLekakisILiatisSVamvakouGZoumakisEet al

They are sold solely for scientific research, analytical testing, and educational purposes

Funding No funding was received from any funding agency or organization

El cido valproico es un medicamento bastante txico, por lo que en muchos pases se prohbe su administracin en nios pequeos

Abstract It is well established that the involvement of reactive species in the pathophysiology of several neurological diseases, including phenylketonuria (PKU), a metabolic genetic disorder biochemically characterized by elevated levels of phenylalanine (Phe)